ContextVision presents First Quarter 2014 report


  • Strong first quarter sales

  • Acquisition of unique 3D rendering technology

  • Milestone for new technology platform reached


  • Sales of 17.6 MSEK (15.9)

  • Operating result of 1.8 MSEK (1.2) and operating margin of 10.5% (7.1%).

  • Earnings per share of 0,20 (0,12) SEK

A video presentation by CEO Anita Tollstadius will be submitted on Friday, April 25th, at 09.00 CET.

Please follow the link

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit

Documents & Links